PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAvanir Pharmaceuticals
Avanir Pharmaceuticals(AVNR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
NuedextaDextromethorphan, Quinidine2010-10-292023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Toothache
,
Dysmenorrhea
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dextromethorphan
healthy volunteers/patients
,
schizophrenia
,
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
dyskinesias
,
psychomotor agitation
,
neuralgia
,
migraine disorders
,
disease progression
,
sclerosis
,
parkinson disease
,
multiple sclerosis
,
amyotrophic lateral sclerosis
,
pain
,
diabetic neuropathies
,
motor neuron disease
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
,
brain injuries
,
dementia
Quinidine gluconate
healthy volunteers/patients
,
major depressive disorder
,
depressive disorder
Quinidine polygalacturonate
healthy volunteers/patients
,
major depressive disorder
,
depressive disorder
Quinidine
healthy volunteers/patients
,
schizophrenia
,
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
dyskinesias
,
psychomotor agitation
,
neuralgia
,
migraine disorders
,
disease progression
,
sclerosis
,
parkinson disease
,
multiple sclerosis
,
amyotrophic lateral sclerosis
,
pain
,
diabetic neuropathies
,
motor neuron disease
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
,
brain injuries
,
dementia
Neurodex
pain
,
diabetic neuropathies
Antineoplaston a10
healthy volunteers/patients
,
smoking cessation
,
melanoma
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
,
neoplasms
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
heart failure
,
diastolic heart failure
,
down syndrome
,
syndrome
,
cognitive dysfunction
,
anxiety disorders
,
generalized anxiety disorder
,
depression
,
major depressive disorder
,
depressive disorder
,
tonsillitis
,
critical illness
,
delirium
,
psychomotor agitation
,
post-traumatic stress disorders
,
executive function
,
cardiovascular diseases
,
ischemia
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
cardiomyopathies
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use